BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Beyoğlu D, Idle JR. Metabolomic insights into the mode of action of natural products in the treatment of liver disease. Biochemical Pharmacology 2020;180:114171. [DOI: 10.1016/j.bcp.2020.114171] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zheng Y, Yu Z, Li Y, Zhong S, Sun Y, Sun L, Zheng X, Qi X, Zhang S. Alcohol extracts of Chinese bayberry branch induce S‐phase arrest and apoptosis in H ep G 2 cells. Food Science & Nutrition. [DOI: 10.1002/fsn3.3080] [Reference Citation Analysis]
2 Beyoğlu D, Idle JR. The gut microbiota - a vehicle for the prevention and treatment of hepatocellular carcinoma. Biochem Pharmacol 2022;:115225. [PMID: 35998677 DOI: 10.1016/j.bcp.2022.115225] [Reference Citation Analysis]
3 Beyoğlu D, Simillion C, Storni F, De Gottardi A, Idle JR. A Metabolomic Analysis of Cirrhotic Ascites. Molecules 2022;27:3935. [PMID: 35745058 DOI: 10.3390/molecules27123935] [Reference Citation Analysis]
4 Chen C, Duan F, Xie Y, Wan Q, Liu H, Gong J, Huang L, Song Z. Nuciferine attenuates acute ischemic stroke in a rat model: a metabolomic approach for the mechanistic study. Mol Omics 2022;18:765-778. [DOI: 10.1039/d2mo00158f] [Reference Citation Analysis]
5 Sun R, Zhao H, Huang S, Zhang R, Lu Z, Li S, Wang G, Aa J, Xie Y. Prediction of Liver Weight Recovery by an Integrated Metabolomics and Machine Learning Approach After 2/3 Partial Hepatectomy. Front Pharmacol 2021;12:760474. [PMID: 34916939 DOI: 10.3389/fphar.2021.760474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bortnikova VV, Karabaeva VV, Krepkova LV, Mizina PG, Babenko AN, Mikheeva NS, Karabaeva ON. A Retrospective Analysis of the Clinical Studies of a Drug "Flakozid" in the Treatment of Diseases of the Hepatobiliary System. Razrabotka i registraciâ lekarstvennyh sredstv 2021;10:100-4. [DOI: 10.33380/2305-2066-2021-10-3-100-104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Yan J, Nie Y, Luo M, Chen Z, He B. Natural Compounds: A Potential Treatment for Alcoholic Liver Disease? Front Pharmacol 2021;12:694475. [PMID: 34290612 DOI: 10.3389/fphar.2021.694475] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
8 Zhang Y, Zhou Q, Ding X, Ma J, Tan G. Chemical profile of Swertia mussotii Franch and its potential targets against liver fibrosis revealed by cross-platform metabolomics. J Ethnopharmacol 2021;274:114051. [PMID: 33746001 DOI: 10.1016/j.jep.2021.114051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]